US 7229972
3,6-Bicyclolides
granted A61PA61P31/04
Quick answer
US patent 7229972 (3,6-Bicyclolides) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P31/04